| UniProt ID | FCL_HUMAN | |
|---|---|---|
| UniProt AC | Q13630 | |
| Protein Name | GDP-L-fucose synthase | |
| Gene Name | TSTA3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 321 | |
| Subcellular Localization | ||
| Protein Description | Catalyzes the two-step NADP-dependent conversion of GDP-4-dehydro-6-deoxy-D-mannose to GDP-fucose, involving an epimerase and a reductase reaction.. | |
| Protein Sequence | MGEPQGSMRILVTGGSGLVGKAIQKVVADGAGLPGEDWVFVSSKDADLTDTAQTRALFEKVQPTHVIHLAAMVGGLFRNIKYNLDFWRKNVHMNDNVLHSAFEVGARKVVSCLSTCIFPDKTTYPIDETMIHNGPPHNSNFGYSYAKRMIDVQNRAYFQQYGCTFTAVIPTNVFGPHDNFNIEDGHVLPGLIHKVHLAKSSGSALTVWGTGNPRRQFIYSLDLAQLFIWVLREYNEVEPIILSVGEEDEVSIKEAAEAVVEAMDFHGEVTFDTTKSDGQFKKTASNSKLRTYLPDFRFTPFKQAVKETCAWFTDNYEQARK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 7 | Phosphorylation | -MGEPQGSMRILVTG -CCCCCCCEEEEEEC | 10.31 | 24719451 | |
| 13 | Phosphorylation | GSMRILVTGGSGLVG CCEEEEEECCCCHHH | 32.17 | 20068231 | |
| 16 | Phosphorylation | RILVTGGSGLVGKAI EEEEECCCCHHHHHH | 30.23 | 20860994 | |
| 21 | Ubiquitination | GGSGLVGKAIQKVVA CCCCHHHHHHHHHHH | 34.53 | 21906983 | |
| 25 | Ubiquitination | LVGKAIQKVVADGAG HHHHHHHHHHHCCCC | 32.34 | - | |
| 42 | Phosphorylation | GEDWVFVSSKDADLT CCCEEEEECCCCCCC | 21.87 | 28348404 | |
| 43 | Phosphorylation | EDWVFVSSKDADLTD CCEEEEECCCCCCCC | 29.29 | 28348404 | |
| 44 | Ubiquitination | DWVFVSSKDADLTDT CEEEEECCCCCCCCH | 49.80 | 21906983 | |
| 81 | Acetylation | GGLFRNIKYNLDFWR HHHHHHHCCCHHHHH | 31.47 | 26051181 | |
| 82 | Phosphorylation | GLFRNIKYNLDFWRK HHHHHHCCCHHHHHH | 19.70 | 27251275 | |
| 89 | Ubiquitination | YNLDFWRKNVHMNDN CCHHHHHHCCCCCCC | 54.65 | - | |
| 111 | Phosphorylation | VGARKVVSCLSTCIF HCHHHHHHHHHHCCC | 16.60 | 30622161 | |
| 114 | Phosphorylation | RKVVSCLSTCIFPDK HHHHHHHHHCCCCCC | 26.09 | 30622161 | |
| 115 | Phosphorylation | KVVSCLSTCIFPDKT HHHHHHHHCCCCCCC | 9.18 | 30622161 | |
| 147 | Acetylation | NFGYSYAKRMIDVQN CCCHHHHHHHHHCCC | 33.98 | 23954790 | |
| 200 | Phosphorylation | HKVHLAKSSGSALTV EEEEEHHCCCCCEEE | 34.03 | 20068231 | |
| 201 | Phosphorylation | KVHLAKSSGSALTVW EEEEHHCCCCCEEEE | 35.74 | 20068231 | |
| 203 | Phosphorylation | HLAKSSGSALTVWGT EEHHCCCCCEEEECC | 23.27 | 25693802 | |
| 206 | Phosphorylation | KSSGSALTVWGTGNP HCCCCCEEEECCCCC | 17.58 | 25693802 | |
| 287 | Phosphorylation | FKKTASNSKLRTYLP EEEEECCCCCHHCCC | 30.48 | - | |
| 306 | Ubiquitination | TPFKQAVKETCAWFT CCHHHHHHHHHHHHH | 50.77 | - | |
| 316 | Phosphorylation | CAWFTDNYEQARK-- HHHHHCCHHHHHC-- | 16.54 | 20068231 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FCL_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FCL_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FCL_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RBBP7_HUMAN | RBBP7 | physical | 22863883 | |
| PCBP3_HUMAN | PCBP3 | physical | 26186194 | |
| ARFP1_HUMAN | ARFIP1 | physical | 26344197 | |
| G6PD_HUMAN | G6PD | physical | 26344197 | |
| GALE_HUMAN | GALE | physical | 26344197 | |
| HNRH1_HUMAN | HNRNPH1 | physical | 26344197 | |
| KDM3A_HUMAN | KDM3A | physical | 26344197 | |
| NTM1A_HUMAN | NTMT1 | physical | 26344197 | |
| MSS4_HUMAN | RABIF | physical | 26344197 | |
| SC31A_HUMAN | SEC31A | physical | 26344197 | |
| XPO1_HUMAN | XPO1 | physical | 26344197 | |
| PCBP3_HUMAN | PCBP3 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-147, AND MASS SPECTROMETRY. | |